Ana Cenarro

Ana Cenarro

Auto-generated profile, based on publicly available information

Ana Cenarro

Unidad Clínica y de Investigación en Lípidos y Arteriosclerosis, Hospital Universitario Miguel Servet, Instituto de Investigación Sanitaria Aragón (IIS Aragón), Zaragoza. Centro de Investigación Biomédica en Red Cardiovascular (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain (Drs Gracia-Rubio, Lamiquiz-Moneo, Bea, Marco-Benedí, Civeira, and Cenarro); Instituto Aragonés de Ciencias de la Salud (IACS), Zaragoza, Spain (Dr Cenarro)

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2011 in British Journal of Nutrition
Verified
Journal Article
Open access
PDF file
Rocio Mateo-GallegoRocio Mateo-Gallego
Rocio Mateo-Gallego
SPSofía Pérez-Calahorra
Sofía Pérez-Calahorra
ACAna Cenarro
Ana Cenarro
ABAna M. Bea
Ana M. Bea
EAEva Andres
Eva Andres
FCFernando Civeira
Fernando Civeira
The main dietary guidelines recommend restricting total and saturated fat intake in the management of high blood cholesterol levels for cardiovascular risk. These recommendations are usually oversimplified by considering that all red meats should be limited and replaced by white meats. However, lean red meat can be as low in fat as white meat. We examined the effects of red meat (lean breed lamb) and lean white meat (chicken) intake on the lipid profile of a group of women with stable life conditions (nuns living in convents). An open-label, randomised, cross-over study was carried out in thirty-six nuns who consumed either lamb or chicken three times per week for 5-week periods with their usual diet. Clinical, dietary and biochemical variables were evaluated at baseline and the end of each diet period. A validated FFQ was used to assess nutrient intake and monitor compliance. The results showed neither between-diet differences in lipid responses nor differences from baseline in total cholesterol, LDL-cholesterol or TAG for any diet period. In conclusion, consumption of lean red meat (lamb) or lean white meat (chicken) as part of the usual diet is associated with a similar lipid response. These two foods can be exchanged in a healthy diet to increase palatability.

1 March 2018 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
LBLucía Baila-Rueda
Lucía Baila-Rueda
ACAna Cenarro
Ana Cenarro
ILItziar Lamiquiz-Moneo
Itziar Lamiquiz-Moneo
SPSofía Pérez-Calahorra
Sofía Pérez-Calahorra
ABAna M. Bea
Ana M. Bea
FCFernando Civeira
Fernando Civeira

9 September 2023 in Journal of Clinical Lipidology
Verified
Journal Article
Closed access
VMVictoria Marco-Benedí
Victoria Marco-Benedí
ACAna Cenarro
Ana Cenarro
ÀVÀlex Vila
Àlex Vila
JRJosé T. Real
José T. Real
JTJuan J. Tamarit
Juan J. Tamarit
AVAntonio J. Vallejo Vaz
Antonio J. Vallejo Vaz

2 December 2025 in Journal of Clinical Lipidology
Verified
Journal Article
Open access
IGIrene Gracia-Rubio
Irene Gracia-Rubio
AVAsier Benito vicente
Asier Benito vicente
ILItziar Lamiquiz-Moneo
Itziar Lamiquiz-Moneo
ABAna María Bea
Ana María Bea
VMVictoria Marco-Benedí
Victoria Marco-Benedí
ACAna Cenarro
Ana Cenarro
Rare variants in SCARB1, which encodes the high-density lipoprotein (HDL) receptor scavenger receptor class B type 1 (SR-B1), are hypothesized to drive unexplained extreme levels of plasma HDL cholesterol (HDL-C). We sequenced and phenotypically correlated SCARB1 by analyzing individuals with extreme HDL-C levels and characterizing the functional consequences of rare identified variants. SCARB1 was Sanger-sequenced in 96 unrelated participants with extreme HDL-C levels. Clinical, biochemical, and anthropometric data were compared between groups. Bioinformatic tools were used to predict the functional impact of all detected variants. Familial analyses of predicted damaging in silico or not previously described variants was assessed, and HDL uptake was quantified by flow cytometry in HEK293 cells expressing rare SCARB1 variants showing a suggestive pattern of familial segregation. Compared with the high-HDL-C group, low-HDL-C subjects exhibited lower low-density lipoprotein cholesterol and total cholesterol but higher triglycerides, higher body mass index, and a greater frequency of atherosclerotic cardiovascular disease events. Twenty-five SCARB1 variants were identified; 4 of them, c.-177G>T, p.(Thr118Ser), c.843-982G>A and p.(Thr378Met), were predicted to be deleterious. The missense changes p.(Thr118Ser) and p.(Thr378Met) showed a suggestive pattern of segregation with high HDL-C in available pedigrees. Cells expressing p.(Thr378Met) SCARB1 variant showed a reduction in HDL uptake vs wild-type. Rare predicted damaging in silico variant in SCARB1, p.(Thr378Met), impairs SR-B1-mediated HDL uptake and associates with high HDL-C levels, highlighting SCARB1 as a candidate gene for genetic screening in dyslipidemic patients.

1 August 2021 in Atherosclerosis
Verified
Journal Article
Closed access
PDF file
IGIrene Gracia-Rubio
Irene Gracia-Rubio
ABA.M. Bea
A.M. Bea
ILI. Lamiquiz-Moneo
I. Lamiquiz-Moneo
VMVito Di Marco
Vito Di Marco
CMC. Martín
C. Martín
FCFernando Civeira
Fernando Civeira